Benjamin Thompson, Noah Baker, and Amy Maxmen discuss Trump withholding funds from the WHO, and how COVID-19 kills. We also hear about controlling misinformation while communicating risk.
In this episode:
01:15 Understanding bottlenecks
After listening to last week’s episode of Coronapod, researchers in the USA were inspired to start collecting data about the challenges facing labs carrying out testing. After more than 4,000 responses to their online survey, we discuss their goals.
03:08 A hole in the WHO’s funding
US President Donald Trump has announced plans to withhold funding for the WHO, pending a review of the organization’s handling of the pandemic. We discuss the decision and ask what it means for the global response to COVID-19.
News: Nature‘s rolling coronavirus news blog
05:55 Responding to the immune system
We investigate the role of the immune system in the death of COVID-19 patients and what this could mean for treatments. Could some therapeutics actually be undermining the body’s ability to fight the virus?
News: How does COVID-19 kill? Uncertainty is hampering doctors’ ability to choose treatments
13:54 One good thing this week
Our hosts pick out things that have made them smile in the last 7 days, including seasonal memories from Sierra Leone, a trip to the supermarket, and the 99-year old war veteran who has raised millions for charity.
BBC News: Coronavirus: Capt Tom Moore’s NHS fundraiser hits £17m
18:33 Communicating complex data
Clearly communicating risks and evidence is key for governments and other organisations if they are to best inform the public during the pandemic. But what is the best way to do it? We hear the methods that communications experts and behavioural scientists recommend to keep the public informed, and keep misinformation at bay.
We observed that increased adherence to the MedDiet modulates specific components of the gut microbiota that were associated with a reduction in risk of frailty, improved cognitive function and reduced inflammatory status.
The hope, Lee says, is that ultrasound will kill cancer cells in a specific way that will also engage the immune system and arouse it to attack any cancer cells remaining after the treatment.
Ultrasound waves—sound waves with frequencies higher than humans can hear—have been used as a cancer treatment before, albeit in a broad-brush approach: high-intensity bursts of ultrasound can heat up tissue, killing cancer and normal cells in a target area. Now, scientists and engineers are exploring the use of low-intensity pulsed ultrasound (LIPUS) in an effort to create a more selective treatment.
Scientists have just discovered a new mechanism that can be key in regulating these immune attacks, raising new hopes of drugs that can protect against joint inflammation and the ailments it can bring.
Boomers Daily 